文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

氧疗与医护人员照护病毒性严重急性呼吸道感染患者的感染风险:系统评价与Meta分析

Oxygen Therapy and Risk of Infection for Health Care Workers Caring for Patients With Viral Severe Acute Respiratory Infection: A Systematic Review and Meta-analysis.
PubMed 文献 · Ann Emerg Med · 2020-08-10
一句话结论多数氧疗方式与医护人员感染风险增加相关,应使用维持 adequate 氧饱和度的最低氧流量并尽量减少氧疗设备操作。

该系统评价与Meta分析检索了2000年1月1日至2020年4月1日的MEDLINE、EMBASE和Cochrane Central Register of Controlled Trials,纳入50项研究进行定性合成、16项进行Meta分析,评估不同氧疗方式治疗病毒性严重急性呼吸道感染患者时医护人员的感染风险。结果显示,暴露于或实施气管插管(OR 6.48,95%CI 2.90–14.44)、球囊-面罩通气(OR 2.70,95%CI 1.31–5.36)和无创通气(OR 3.96,95%CI 2.12–7.40)与感染风险增加相关,所有氧疗方式均产生空气分散。纳入研究证据质量极低。结论建议对病毒性严重急性呼吸道感染患者使用维持 adequate 氧饱和度的最低氧流量,并尽量减少氧疗设备操作。

要点

  • 暴露于或实施气管插管与医护人员感染风险增加相关(OR 6.48,95%CI 2.90–14.44)。
  • 球囊-面罩通气与医护人员感染风险增加相关(OR 2.70,95%CI 1.31–5.36)。
  • 无创通气与医护人员感染风险增加相关(OR 3.96,95%CI 2.12–7.40)。
  • 所有氧疗方式均产生空气分散,且没有一种被证明是安全的。
  • 对病毒性严重急性呼吸道感染患者应使用维持 adequate 氧饱和度的最低氧流量,并尽量减少氧疗设备操作。

适用人群与场景

  • 照护病毒性严重急性呼吸道感染患者的医护人员。

处置流程与药物剂量

  • 对病毒性严重急性呼吸道感染患者使用维持 adequate 氧饱和度的最低氧流量。
  • 尽量减少氧疗设备操作。

研究设计与关键结果

  • 系统评价与Meta分析,检索2000年1月1日至2020年4月1日MEDLINE、EMBASE和Cochrane Central Register of Controlled Trials,22,123条引用中50项研究纳入定性合成、16项纳入Meta分析。
  • 暴露于或实施气管插管与医护人员感染风险增加相关(OR 6.48,95%CI 2.90–14.44)。
  • 球囊-面罩通气与医护人员感染风险增加相关(OR 2.70,95%CI 1.31–5.36)。
  • 无创通气与医护人员感染风险增加相关(OR 3.96,95%CI 2.12–7.40)。
  • 所有氧疗方式均产生空气分散。

证据类型、等级与局限

  • 系统评价与Meta分析,纳入研究证据质量极低。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对病毒性严重急性呼吸道感染患者,应使用维持 adequate 氧饱和度的最低氧流量,并尽量减少氧疗设备操作。
  • 气管插管、球囊-面罩通气和无创通气与医护人员感染风险增加相关,应注意防护。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: To synthesize the evidence regarding the infection risk associated with different modalities of oxygen therapy used in treating patients with severe acute respiratory infection. Health care workers face significant risk of infection when treating patients with a viral severe acute respiratory infection. To ensure health care worker safety and limit nosocomial transmission of such infection, it is crucial to synthesize the evidence regarding the infection risk associated with different modalities of oxygen therapy used in treating patients with severe acute respiratory infection.

METHODS: MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials were searched from January 1, 2000, to April 1, 2020, for studies describing the risk of infection associated with the modalities of oxygen therapy used for patients with severe acute respiratory infection. The study selection, data extraction, and quality assessment were performed by independent reviewers. The primary outcome measure was the infection of health care workers with a severe acute respiratory infection. Random-effect models were used to synthesize the extracted data.

RESULTS: Of 22,123 citations, 50 studies were eligible for qualitative synthesis and 16 for meta-analysis. Globally, the quality of the included studies provided a very low certainty of evidence. Being exposed or performing an intubation (odds ratio 6.48; 95% confidence interval 2.90 to 14.44), bag-valve-mask ventilation (odds ratio 2.70; 95% confidence interval 1.31 to 5.36), and noninvasive ventilation (odds ratio 3.96; 95% confidence interval 2.12 to 7.40) were associated with an increased risk of infection. All modalities of oxygen therapy generate air dispersion.

CONCLUSION: Most modalities of oxygen therapy are associated with an increased risk of infection and none have been demonstrated as safe. The lowest flow of oxygen should be used to maintain an adequate oxygen saturation for patients with severe acute respiratory infection, and manipulation of oxygen delivery equipment should be minimized.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Cournoyer A, Grand'Maison S, Lonergan AM, et al. Oxygen Therapy and Risk of Infection for Health Care Workers Caring for Patients With Viral Severe Acute Respiratory Infection: A Systematic Review and Meta-analysis. Ann Emerg Med. 2020. PMID: 32788066. doi:10.1016/j.annemergmed.2020.06.037

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。